| pubmed-article:17445650 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C1336527 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0016315 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:17445650 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
| pubmed-article:17445650 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17445650 | pubmed:dateCreated | 2007-4-20 | lld:pubmed |
| pubmed-article:17445650 | pubmed:abstractText | Several studies have shown that 5-aminolevulinic acid (5-ALA)-induced fluorescence cystoscopy improves the detection of superficial bladder cancer. The results have suggested a reduced rate of recurrent tumors with the use of 5-ALA fluorescence before bladder tumor resection. We performed a prospective, randomized trial to investigate whether the long-term tumor recurrence and residual tumor rates can be decreased using 5-ALA fluorescence diagnosis (FD). | lld:pubmed |
| pubmed-article:17445650 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17445650 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17445650 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17445650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17445650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17445650 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17445650 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17445650 | pubmed:issn | 1527-9995 | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:KnuechelRuthR | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:FilbeckThomas... | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:WielandWolf... | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:RoesslerWolfg... | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:WalterBernhar... | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:BurgerMaximil... | lld:pubmed |
| pubmed-article:17445650 | pubmed:author | pubmed-author:DenzingerStef... | lld:pubmed |
| pubmed-article:17445650 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17445650 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:17445650 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17445650 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17445650 | pubmed:pagination | 675-9 | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:meshHeading | pubmed-meshheading:17445650... | lld:pubmed |
| pubmed-article:17445650 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17445650 | pubmed:articleTitle | Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. | lld:pubmed |
| pubmed-article:17445650 | pubmed:affiliation | Department of Urology, University of Regensburg, Regensburg, Germany. stefandenzinger@hotmail.com | lld:pubmed |
| pubmed-article:17445650 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17445650 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17445650 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17445650 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17445650 | lld:pubmed |
